Association between adiponectin, resistin, insulin resistance, and colorectal tumors

被引:83
作者
Gonullu, Guzin [1 ]
Kahraman, Hakki [2 ]
Bedir, Abdulkerim [3 ]
Bektas, Ahmet [4 ]
Yucel, Idris [1 ]
机构
[1] Ondokuz Mayis Univ, Sch Med, Dept Med Oncol, TR-55139 Kurupelit, Samsun, Turkey
[2] Ondokuz Mayis Univ, Sch Med, Dept Endocrinol, TR-55139 Kurupelit, Samsun, Turkey
[3] Ondokuz Mayis Univ, Sch Med, Dept Biochem, TR-55139 Kurupelit, Samsun, Turkey
[4] Ondokuz Mayis Univ, Sch Med, Dept Gastroenterol, TR-55139 Kurupelit, Samsun, Turkey
关键词
Adiponectin; Resistin; Colon; Tumors; ADIPOSE-SPECIFIC PROTEIN; PLASMA ADIPONECTIN; SERUM ADIPONECTIN; PHYSICAL-ACTIVITY; COLON-CANCER; RISK-FACTORS; LEPTIN; ATHEROSCLEROSIS; EXPRESSION; OBESITY;
D O I
10.1007/s00384-009-0828-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In this study, we have examined the correlation between colorectal cancer (CRC) and serum adiponectin and resistin levels, body mass index and insulin resistance. The relation between serum adiponectin and resistin levels, obesity and insulin resistance in 36 CRC patients and 37 controls was examined. Insulin and homeostasis model assessment insulin resistance index (HOMA-IR) levels were higher, and adiponectin levels were significantly decreased in patients versus controls, whereas, resistin levels were significantly increased. A negative correlation between adiponectin, HOMA-IR, and insulin and a positive correlation between HOMA-IR, insulin, and stage were detected. There was no correlation between the stage and resistin. Adiponectin level negatively correlated with the stage. Adiponectin and resistin could play a role in colon cancer carcinogenesis, and adiponectin could be responsible for poor prognosis in colorectal cancer.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 49 条
[1]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[2]   Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis [J].
Bråkenhielm, E ;
Veitonmäki, N ;
Cao, RH ;
Kihara, S ;
Matsuzawa, YJ ;
Zhivotovsky, B ;
Funahashi, T ;
Cao, YH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) :2476-2481
[3]   REPRODUCTIVE, MENSTRUAL, AND MEDICAL RISK-FACTORS FOR ENDOMETRIAL CANCER - RESULTS FROM A CASE-CONTROL STUDY [J].
BRINTON, LA ;
BERMAN, ML ;
MORTEL, R ;
TWIGGS, LB ;
BARRETT, RJ ;
WILBANKS, GD ;
LANNOM, L ;
HOOVER, RN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (05) :1317-1325
[4]   Reproducibility and validity of a self administered physical activity questionnaire for male health professionals [J].
ChasanTaber, S ;
Rimm, EB ;
Stampfer, MJ ;
Spiegelman, D ;
Colditz, GA ;
Giovannucci, E ;
Ascherio, A ;
Willett, WC .
EPIDEMIOLOGY, 1996, 7 (01) :81-86
[5]   The role of the novel adipocyte-derived hormone adiponectin in human disease [J].
Díez, JJ ;
Iglesias, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (03) :293-300
[6]  
ERASLAN E, 2009, DIGEST DIS SCI, V54, P862
[7]   Adipose tissue, adipokines, and inflammation [J].
Fantuzzi, G .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) :911-919
[8]  
Ferroni P, 2007, ANTICANCER RES, V27, P483
[9]   Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition [J].
Fujisawa, T. ;
Endo, H. ;
Tomimoto, A. ;
Sugiyama, M. ;
Takahashi, H. ;
Saito, S. ;
Inamori, M. ;
Nakajima, N. ;
Watanabe, M. ;
Kubota, N. ;
Yamauchi, T. ;
Kadowaki, T. ;
Wada, K. ;
Nakagama, H. ;
Nakajima, A. .
GUT, 2008, 57 (11) :1531-1538
[10]   Diurnal and ultradian dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor, and cortisol patterns [J].
Gavrila, A ;
Peng, CK ;
Chan, JL ;
Mietus, JE ;
Goldberger, AL ;
Mantzoros, CS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2838-2843